Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Brain implant allows ALS patient to control Amazon’s Alexa with thought: ‘Gives me back the independence that I’m losing’
To be able to manage important aspects of my environment and control access to entertainment gives me back the independence that I’m losing.”
Brain implant lets man with amyotrophic lateral sclerosis control Amazon's Alexa with his thoughts
A patient with a degenerative disease was able to command Amazon's Alexa digital assistant with his mind, the company behind the
Synchron Connects Brain Implant to Amazon Alexa
Synchron is one of several companies working to make brain-computer interfaces (BCIs) a reality. Earlier this summer, Synchron revealed one of its study participants could use the Apple Vision Pro VR headset thanks to the Synchron implant.
64-year-old ALS patient controls Alexa with just his thoughts
A 64-year-old ALS patient successfully controlled Alexa using his thoughts through a brain implant, allowing him to perform tasks like making video calls, playing music, and operating smart home devices.
Man controls Amazon Alexa with his thoughts, ‘It gives me back the independence’
An ALS patient manipulated Amazon's Alexa through a brain implant, enabling him to control devices and stream shows mentally. This advancement illustrates the potential of brain-computer interfaces to provide independence to those with degenerative diseases,
ALS patient uses brain chip to control Alexa, shop, stream with just thoughts
On Monday, Synchron, a brain-computer interface (BCI) company, announced this development, revealing that the 64-year-old patient, diagnosed with amyotrophic lateral sclerosis (ALS), can stream shows,
Too Old to Operate
13h
CATS-A ARQ Measures Cognitive Impairment in ALS with High Accuracy
The following is a summary of “How to detect affect recognition alterations in amyotrophic lateral sclerosis,” published in the September 2024 issue of Neurology by Castelnovo et al. Researchers condu ...
13d
on MSN
New research identifies potential therapeutic target for amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is the most common degenerative motor neuron disease ...
Medscape
7d
ALS Blood Test Promises Accurate, Earlier Diagnosis
A blood test has been shown to accurately identify patients with amyotrophic lateral sclerosis at early stages, which could ...
News Medical on MSN
10d
New blood test achieves 98% accuracy in diagnosing ALS
A highly accurate diagnostic blood test has been developed for amyotrophic lateral sclerosis (ALS), a progressive ...
ktvq
22h
'Just fantastic': Billings ZooMontana hosts hundreds for inaugural ALS walk
BILLINGS — Hundreds gathered at ZooMontana for the first ever ALS walk in Billings, hoping to raise funds for research and ...
8h
Clover Health Medicare Advantage Review 2024
When comparing Clover Health Medicare Advantage to two other randomly chosen Medicare Advantage plans offered by large health ...
4d
Prince William and Kate Middleton Support New Book About Late Rugby Star Who Died From ALS
Prince William and Kate Middleton have offered their support to Lindsey Burrow, the widow of late British rugby star Rob ...
Pharmaceutical Technology
14d
Siplizumab by ITB-Med for Amyotrophic Lateral Sclerosis: Likelihood of Approval
Siplizumab is under clinical development by ITB-Med and currently in Phase I for Amyotrophic Lateral Sclerosis.
The Lancet
4d
Trial designs for motor neuron disease in the 21st century
Motor neuron diseases are a group of progressive and ultimately fatal neurodegenerative disorders of the motor system, ...
ALS News Today
8h
Short course of treatment with RNS60 extends survival in ALS
A short course of treatment with RNS60, as an add-on to riluzole, extended the survival of ALS patients by about six months, ...
Pharmaceutical Technology
14d
Fasudil by Woolsey Pharmaceuticals for Amyotrophic Lateral Sclerosis: Likelihood of Approval
Fasudil is under clinical development by Woolsey Pharmaceuticals and currently in Phase II for Amyotrophic Lateral Sclerosis.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback